Skip to content

Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600

Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05463198
Enrollment
351
Registered
2022-07-18
Start date
2022-09-14
Completion date
2023-05-26
Last updated
2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Loss

Brief summary

The study is a prospective, non-randomized, non-blinded, non-significant risk, multi-center study enrolling up to 500 healthy adult subjects consented to undergo a whole blood donation procedure. The study will involve enrolling subjects that will undergo blood donation wearing the study device (CM-1600 Device) and capture study-required physiological parameters pre-, during, and post-donation.

Interventions

DEVICECM-1600

Subjects undergoing blood donation will be connected to the CM-1600 device.

Sponsors

Zynex Monitoring Solutions
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ability to provide written consent * Ability and willingness to comply with the study procedures and duration requirements * 18 years of age or older * Consented and eligible to undergo a single unit whole blood donation

Exclusion criteria

* Females who are pregnant or breastfeeding * Undergone an amputation of any upper extremity * Diagnosed with dextrocardia * Subjects who have a pacemaker * Subjects with body hair density which prevents adequate application of device electrodes

Design outcomes

Primary

MeasureTime frameDescription
Change in the Relative Index (RI) After Minor Blood Loss (e.g., 500mL)Recovery period following donation (10 minutes)The objective of this study is to determine if manual blood loss of up to 500mL of blood can be identified using the non-invasive Zynex CM-1600. This will be measured by determining the percent change in Relative Index (RI) before and after the Blood Draw. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set minimum or maximum, where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Countries

United States

Participant flow

Participants by arm

ArmCount
Blood Loss
CM-1600: Subjects undergoing blood donation will be connected to the CM-1600 device.
314
Total314

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProcedure Notes Missing18
Overall StudyWithdrawal by Subject19

Baseline characteristics

CharacteristicBlood Loss
Age, Continuous43.8 years
STANDARD_DEVIATION 21.4
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
314 participants
Sex: Female, Male
Female
193 Participants
Sex: Female, Male
Male
121 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 351
other
Total, other adverse events
4 / 351
serious
Total, serious adverse events
0 / 351

Outcome results

Primary

Change in the Relative Index (RI) After Minor Blood Loss (e.g., 500mL)

The objective of this study is to determine if manual blood loss of up to 500mL of blood can be identified using the non-invasive Zynex CM-1600. This will be measured by determining the percent change in Relative Index (RI) before and after the Blood Draw. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set minimum or maximum, where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Time frame: Recovery period following donation (10 minutes)

Population: 18 subjects were unevaluable; 19 subjects were withdrawn

ArmMeasureValue (MEAN)Dispersion
Blood LossChange in the Relative Index (RI) After Minor Blood Loss (e.g., 500mL)2.9 Percent change in RIStandard Deviation 151.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026